Home / Research Library / REGENESIS · Cellular and Tissue-Model Research
REGENESIS · Cellular and Tissue-Model Research

The GLOW Stack Explained: BPC-157, TB-500 & GHK-Cu

2026-06-08 · ~3 min read · For laboratory and educational use only

All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.

The short version
  • The GLOW stack is a community nickname for three research peptides studied together: BPC-157, TB-500, and GHK-Cu, each tied to a different tissue-repair pathway.
  • The research is early and limited. Most of it is in animals or cells (preclinical), studying things like blood-vessel growth and skin and collagen biology, not proof of what happens in people.
  • There is no published controlled human trial on the GLOW blend itself. Most of the talk about it comes from single-compound studies and unverified personal reports, not solid outcome data.
  • None of these compounds is FDA-approved for human or veterinary use. BPC-157 and TB-500 are on the World Anti-Doping Agency banned list, and the FDA has flagged BPC-157.
  • BioRegen makes no claim that any of this works and sells these strictly for laboratory and educational research, not for human use.

All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. "GLOW" is a nickname that the research community uses for a set of three compounds that get studied a lot: BPC-157, TB-500, and GHK-Cu. This article explains what each one is, why scientists look at it, and how the three are talked about together in lab and educational settings. It does not describe or support any use in people or animals.

What the GLOW stack combines

GLOW puts together three separate research compounds. Each one shows up in published studies on how tissue heals and rebuilds itself. BPC-157 is a lab-made peptide (a short chain of 15 building blocks called amino acids) based on a sequence first found in stomach fluid. TB-500 is a lab-made piece of a natural protein called thymosin beta-4. GHK-Cu is a small three-part peptide (glycine, histidine, and lysine) joined to a copper atom. Researchers talk about the group as a way to study several repair-related body pathways at the same time, instead of one at a time. For background on how scientists sort and tell these compounds apart, see our research finder.

BPC-157: why it is studied

In published studies, BPC-157 has been looked at in animals and in lab dishes as a model of soft-tissue healing. A lot of that work focuses on how the body grows new blood vessels, which scientists call angiogenesis. In muscle and tendon healing models, researchers have linked it to changes in a growth signal called VEGF (vascular endothelial growth factor). Scientists mainly use BPC-157 as a tool to understand how peptide signals fit into the body's healing steps. All of this work so far has been early-stage and done in the lab. No conclusions about what it does in people are drawn here.

TB-500 and GHK-Cu: complementary research targets

TB-500 is studied as a lab-made peptide tied to thymosin beta-4, a natural protein. In lab models, researchers link that protein to how cells move, how a cell's internal scaffolding (called actin) is managed, and how repair signals are sent. GHK-Cu is studied for a different reason: its part in the biology of skin and connective tissue. In published research, GHK has been described as something that can nudge several cell pathways. These include the building and recycling of collagen and other support molecules, and the pulling of repair cells toward injured spots in animal models. Because the three compounds line up with related but separate repair pathways, researchers treat GLOW as a way to study those pathways together in careful lab work. Careful handling matters so results can be repeated. Our guide on how to reconstitute peptides covers lab preparation practices.

How the GLOW stack relates to other research stacks

GLOW is just one of several named combinations the research community talks about. Others include the KLOW stack and the Wolverine stack. They share some of the same compounds with GLOW and swap out others. Comparing the groups helps researchers think about which pathways a given mix is meant to test. For a side-by-side look, see our companion explainers on the KLOW stack and the Wolverine stack. Keep in mind that a lot of online talk about these stacks is just personal stories, not careful studies. BioRegen does not make or back any claims based on those stories.

Frequently asked questions

What does "GLOW stack" mean?

It is a community nickname for a research mix of BPC-157, TB-500, and GHK-Cu. The word just names the group that gets studied in the lab. It does not mean the mix is approved for any use.

Why are these three compounds grouped together?

In published research, each one is tied to a different but related part of how tissue repairs and rebuilds itself. Studying them together lets researchers compare those pathways side by side.

Are these compounds approved for use?

No. None of the compounds named here is approved for use in people or animals. They are sold and discussed only for lab and educational research.

Selected research references

Reference metadata sourced via PubMed.

To learn more about lab methods, check out the BioRegen research guide and create a free account for 10% off your first order. You can also browse the related Regenesis research category for the compounds covered above.

This content is provided for laboratory and educational research only. No compound referenced is approved for human or veterinary use, no therapeutic claims are made, and nothing here is medical advice.

Community & anecdotal, unverifiedWhat is being discussed right now. The three-peptide combination of BPC-157, TB-500, and GHK-Cu circulates widely under the marketing name "GLOW," a label popularized by compounding-pharmacy and wellness-clinic price lists rather than by any research consortium. Recovery-focused and longevity-oriented biohacker communities frequently group the three together on the rationale that each is associated in the literature with a different repair pathway (BPC-157 with angiogenesis, TB-500 with cell migration, and GHK-Cu with collagen and skin remodeling), and skincare and "regenerative aesthetics" circles tend to foreground the GHK-Cu component for reported effects on skin texture. Mainstream and health-trade media coverage over the past year has largely framed these compounds as an unregulated gray-market category, repeatedly noting that BPC-157 and TB-500 appear on the World Anti-Doping Agency (WADA) prohibited list and that none of the three is FDA-approved for injectable human use, with the U.S. FDA having flagged BPC-157 in its compounding-review actions. A recurring and important point in the current conversation is that the combined "GLOW" blend itself has not been the subject of a published controlled human trial; discussion of it draws on single-compound research and on self-reported user accounts rather than on outcome data for the mixture. These are unverified anecdotal reports and current discussion, not controlled findings, and not BioRegen claims.
In the catalog

Shop these research materials

Related research

More peptide research to explore

Explore the research line

Browse the BioRegen catalog, or grab the free reference guide · create a free account for 10% off your first order.